✦ LIBER ✦

Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab

✍ Scribed by M. Herold; A. Schulze; K. Härtwig; G. Anger

Publisher: Springer
Year: 2000
Tongue: English
Weight: 46 KB
Volume: 79
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002779900141

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of B-cell prolympho

Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody

✍ YasserAbou Mourad; Ali Taher; Aref Chehal; Ali Shamseddine 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 118 KB

Treatment of B-cell non-Hodgkin's lympho

Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab

✍ Stefano Sacchi; Massimo Federico; Giuseppe Dastoli; Claudia Fiorani; Giovanni Vi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Rituximab is a chimeric anti CD-20 monoclonal antibody containing human IgG1 kappa constant regions, with murine variable regions. The anti-lymphoma effects of Rituximab are probably due to complement and antibody-dependent cell-mediated cytotoxicity, and induction of apoptosis. Phase II trials have

Rapid tumor lysis in a patient with B-ce

Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)

✍ M. Jensen; U. Winkler; O. Manzke; V. Diehl; A. Engert 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 161 KB

Successful Treatment With a Chimeric Ant

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

✍ Takahiro Maeda; Yasuaki Yamada; Masayuki Tawara; Reishi Yamasaki; Yuichi Yakata; 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 188 KB

Successful treatment of an Epstein-Barr

Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody

✍ Bernard, F. ;Sarran, N. ;Margueritte, G. ;Barneon, G. ;Astruc, J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views